Lorillard
Passive Smoking Mortality A Review and Preliminary Risk Assessment
Fields
- Author
- Wells, A.J.
- Area
- EXECUTIVE FILE ROOM
- Alias
- 92757010/92757027
- Type
- SCRT, SCIENTIFIC REPORT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH/MAPS
- BIBL, BIBLIOGRAPHY
- Site
- N105
- Recipient (Organization)
- Air Pollution Control Assn
- Named Person
- Blot, W.J.
- Brown
- Buckley
- Cantor, K.P.
- Chan
- Colditz, G.A.
- Correa
- Edelman, N.H.
- Fisher, E.B.
- Friedman
- Garfinkel, L.
- Garland
- Gillis
- Hammond
- Hiller, F.C.
- Hirayama
- Kabat
- Knoth
- Koo
- Miller
- Repace, J.L.
- Samet, J.M.
- Sandler
- Sandler, D.P.
- Speizer, F.E.
- Svendsen
- Trichopoulos
- Vandenbroucke
- Wu
- Wynder
- Brown
- Date Loaded
- 05 Jun 1998
- Document File
- 92756800/92757104/Ets - Indoor Air Quality@ 92756801/92757074/Environmental Tobacco Smoke
- Request
- R1-003
- R1-004
- Litigation
- Stmn/Produced
- Master ID
- 92756991/7027
Related Documents:- 92756991-6993 Taxes / Indoor Air Quality
- 92756994 Subcommittee on Natural Resources, Agriculture Research and Environment Hearing on Residential Radon Contamination and Indoor Air Quality Research Needs Witness List
- 92756995-7009 Testimony on Passive Smoking Mortality A Review and Preliminary Risk Assessment by A. Judson Wells, Ph.D. Vice Chairman National Council for Clean Indoor Air Before the Natural Resources, Agriculture Research and Environment Subcommittee of the Committee on Science and Technology U. S. House of Representatives
- Named Organization
- American Lung Assn
- Office of Smoking + Health
- UCSF Legacy ID
- iyh70e00
Document Images
86-80.6
between passive smoking and fatal disease. The lung cancer data
are particularly persuasive, and there are preiiminary data that
indicate an association with total cancer, ischemic heart disease
and emphysema and chronic bronchitis. Third, the cancer patterns
in direct smoking and passive smoking appear to be different.
Cancer Sites
Table IV shows a comparison of cancer sites for direct smoking
(from reference 28), and passive smoking (from Table IIF;). It is
ev i dent that the entry s i tes are di fferent, there i s a
qualitative difference in the location of the lung cancer
sites 29,30 , and the sites elsewhere in the body (except for
cervix) are different. Possible reasons for these differences
are discussed later. One conclusion that can be drawn, however,
Is that passive smokers are not a mixture of true non-smokers and
a small percentage of misclassified direct smokers. Such a
mixture would exhibit the same pattern of excess disease rates as
direct smokers except that the Increases in relative risks would
be smaller.
Table IV. Cancer site aatterns in direct and oassive smokina
Direct Smoking Passive Smoking
Buccal Cavity -
- Nasal Sinus
Pharynx -
Larynx -
Lung - largely Lung - largely
bronchial peripheral
Esophagus -
Stomach -
Urinary Bladder -
Kidney -
Pancreas -
- Breast
- Brain
- Endocrine glands
Cervix Cervix
Particle Size Effects
Probably the most important difference between mainstream and
sidestream smoke Is the difference in effective particle size and
its effect on where the smoke particles are deposited. A careful
study of the smoke and aerosol deposition literature discloses a
number of differences which are summarized in Table V.
Direct smokers retain about 82% 31 of the inhaled particulate of
wh i ch about 37% i s reta i ned i n the bucca 1 cav i ty and 45% i n the
lower respiratory tract. Although particle size measurements
made as mainstream smoke is generated indicate a mass median
9

86-80.6
aerodynamic diameter of about 0.5}anz, the particles, in the moist,
high concentration conditions of direct smoking, apparently
Table V. Deposition patterns in direct and passive smoking.
Entry Site
Particulate inhaled per day, mg.
Effect i ve part i c l e s i ze i nha l ed, ~um.
Percent retained in mouth
Percent retained In nose
Percent retained in bronchus
Percent retained In near alveolar region
Direct P_assive
Mouth
240 a Nose
0.5 to 3.5 b
5 , 0.4
37 '` 0
0 8
20 0
21 0
Percent retained in or near alveoli -A IL
Percent retained, total 82 19
Percent exhaled IS 81
Particle size exhaled, pm 0.7 0.4
aBased on 15 mg. per ci arette and 20 cigarettes per day.
bBased on 100-700 ,ug/m ~32 and 10 1 iters/min. inhaled for S hrs.
agglomerate to a much larger effective particle size. To exhibit
deposition behavior such as that cited above the effective
particle size would have to be in the 5,um range33. This Increase
could be brought about either by direct agglomeration34, by
electrical charges generated on the particles 35, by a dense
layering effect36, or by some combination of these. Particles of
this effective size would deposit heavily in the larger bronchial
a i rways 37 , part i cu l ar l y at the b i furcat i ons, and i n the l arger
airways of the alveolar region. The exhaled smoke has a particle
s i ze of about 0. 7,um 31. On l y about one-f i fth of th i s s i ze wou i d
be deposited, being 25% of the 18% exhaled or about 4% of the
total Inhaled, and this would come down deep in the alveolar
region, in or near the alveoli themselves 33,37.
In contrast sidestream smoke is very dilute. It has a mass
med i an aerodynami c diameter of about 0.4}im3g and does not
agglomerate. This is a very difficult size to trap in the
respiratory tract because It is too large to deposit by diffusion
and too small to deposit by impaction. Some of the larger
particles in the sidestream smoke (about 8% of the amount
inhaled) would be deposited in the nose 33. The other 11% that
will deposit 38 apparently goes all the way through the bronchial
and larger alveolar airways and deposits in or near the
alveol i 33,37.
The particulate from direct smoking is either deposited in the
mouth directly, or in the bronchial region or near alveolar
region where it will be cleared into the mouth. It is then
swallowed and is either eliminated or absorbed Into the blood
stream via the gut. This is believed to result in the cancers
shown in Table IV except possibly for cervix. The particulate
l0

86-80 . 6
from passive smoking deposits either in the nose, resulting In
nasal sinus cancer, or deep in the alveoli from whence it is very
difficult to clear into the mouth. It is speculated that most of
this particulate is solubilized or metabolized'directiy into the
blood or lymph system. It then circulates In these systems and
results in the cancers observed. In passive smoking the
digestive related cancers are absent.
Chemistry and Other Effects
Another difference between mainstream and sidestream smoke is the
chemistry. Side stream smoke Is formed at a lower temperature
than mainstream smoke, and, therefore, a larger fraction of the
more complex molecules is preserved. The amounts of tumorigenic
agents in sidestream and mainstream smoke have been measured 39.
The sidestream/mainstream ratios for such amounts vary from 0.7
for catechol to 39 for 2-naphthylamine. The mean value is 12.
Therefore, It would be expected that sidestream smoke
particulate, per milligram deposited, would have higher
carcinogenic potential than mainstream particulate.
Another difference between direct smoking and passive smoking is
the difference in disease susceptibility between the direct and
passive sfiokers. Deaths attributed to direct smoking constitute
about 18% of total deaths. Thus a direct smoker dying of a
smoking related disease, while perhaps more sensitive than the
average of the total population, would not be substantially more
sensitive. Passive smokers dying of passive smoking disease, on
the other hand, constitute only a very small percentage of total
deaths, in the range of 0.025 to 2.5%. This is a much smaller
proportion than in the case of direct smoking; only the very most
sensitive individuals would be dying from such an effect, and the
expected dose to achieve such a response would be less than that
for a direct smoker.
One approach to predicting the health effects of passive smoking
has been to factor down the health effects of direct smoking by
the ratio of inhaled or deposited smoke dose. As can be seen
from the data in Table V the dose ratio is quite high, being
about 70 to 500 for Inhaled dose and about 300 to 2100 for
deposited dose. However, taking into account the differences in
particle size effects, chemistry and individual susceptibility,
it Is seen that such a simplistic dose/response approach is
unlikely to yield results that are accurate even within an order
of magnitude.
Risk Assessment
Just how dangerous might passive smoking be? Table VI provides a
summary of the combined relative risks for each sex and disease.
Probably the most reliable number In the table is the 1.44
relative risik for female lung cancer, based, as it Is, on eight
11

86-80.6
stud i es i nc l ud i ng those by some of the most promi nent
investigators in the field. The least reliable numbers are those
for male other cancer, where an arbitrary relative risk of 1.0,
denoting no association, was adopted, and for male ischemic heart
disease. Clearly more work Is needed in these areas. The
relative risk for emphysema and chronic bronchitis also has poor
statistical significance, but the underlying death rates for non-
smokers from these diseases is so low that only a very few deaths
would be involved.
,
.
~
Table Vi. Combined Risk Ratios from Eeidemlological Studies
Disease Cases g
/R 2-taii p 951 conf. int.
,
Female:
Lung cancer 463 1.44 <0.001 1.2 - 1.7
Other cancer 2091 1.56 <0.001 1.3 - 1.9
ischemic heart dis. 276 1.27 0.04 1.0 - 1.6
Emphysema & chr. br. 102 1.4 0.18 0.9 - 2.1
li8.L1L=
Lung cancer 13 2.5 0.009 1.3 - 4.7
Other cancer 7 1.0 - -
Ischemic heart dls. 14 1.3 0.46 0.7 - 2.6
To calculate numbers of deaths per year from the relative risks
In Table VI it Is necessary to know the total non-smoking
population, the percent exposed to sidestream smoke and the death
rates for non-smokers by disease category. The non-smoker
population was estimated from the national health statistics.
The percent of non-smokers exposed to spouse's smoke was
estimated from the controls in the U.S. studies In Tables I and
11. Other exposure was estimated using data developed by
Friedman, et a1.40 Non-smoker death rates for each sex and
disease were obtained from Hammond ¢t. By combining these inputs
it was possible to calculate excess death rates due to passive
smoking, again by sex and disease. Applying these death rates to
the non-smoking population passively exposed, the desired number
of deaths per year in the U.S. was obtained. Details of this
calculation are In a manuscript that has been submitted for
publication elsewhere.
By this procedure deaths from passive smoking for lung cancer for
ma l es p l us fema l es came to 1800 per year, we 1 l centered i n the
range of 500 to 5000 obtained in a previous study . For other
cancer and heart disease the relative risks are in the same range
as lung cancer (Table VI), but the underlying non-smoker death
rates are much higher. Therefore, the estimated deaths are much
higher. The total deaths came to 47,000 per year of which 22,000
were from cancer (Including the 1800 lung cancer deaths) and
25,000 were from heart disease. This assumes no excess deaths
from male cancer other than lung but does include deaths from
male ischemic heart disease at a relative risk of 1.3. This
12

86-80.6
value, as noted eariler, Is supported by Svendsen, et a123, and
is very close to the female relative risk of 1.27. Even If these
male deaths are excluded, the total passive smoking deaths would
still calculate out to 32,000 per year.
CONCLUSIONS
The epidemiological literature on mortality from passive smoking
is growing. An association between passive smoking and lung
cancer Is becoming increasingly evident, and th_ere are
beginnings, at least, of evidence that other cancers and heart
disease are also Involved. If these trends continue, lung cancer
will become only the tip of the Iceberg with deaths from these
latter diseases amounting to ten to twenty times those from lung
cancer. Tobacco smoke is known to be carcinogenic and to produce
heart disease. Millions of non-smokers, estimated in this study
at 32 mlliion, are exposed. What we have, in other words, are
the slowly emerging shapes and dimensions of a major public
health problem. Furthermore it is an indoor problem. That means
that it is a home-oriented and workplace problem because that is
where the average passive smoker spends most of his or her time.
There may not be much that can be done about the home setting,
but officials and managers who are responsible for worksites need
to become aware of this increasingiy acknowledged threat to the
safety of Indoor air and the workers who are exposed to it. Also
this is not a traditional workplace air pollutant that emanates
from some facet of the work Itself and on the factory floor.
Rather it occurs in offices, smoke break rooms, washrooms and
other places that have always been considered safe; and the
po l l utant ar i ses not from the work i tsel f but from the other
workers. The first action required is to protect the non-smokers
from the smokers. The next thing to consider is a smoke-free
workplace.
ACKNOWLEOGEMENTS
The author wishes to acknowledge maJor assistance from Graham A.
Co l d'i t z, M. D., who d i d the stat i st i ca l meta-ana l ys i s, and very
helpful suggestions from William J. Blot, Ph.D., Kenneth P.
Cantor, Ph.D., Norman H. Edelman, M.D., Edwin B. Fisher, Ph.D.,
F. Charles Hiller, M.D., James L. Repace, Ph.D., Jonathan M.
Samet, M.D., Dale P. Sandier, Ph.D., and Frank E. Speizer, M.D.
This work was supported In part by the American Lung Association.
The opinions expressed are those of the author. No official
endorsement by the American Lung Association should be inferred.
13

86-80.6
REFERENCES
1. T. Htrayama, "Non-smoking wives of heavy smokers have a
higher risk of lung cancer: a study from Japan", Or_Med.
J.A. LU:183 (1981.).
2. D. Trichopoulos, A. Kaiandidi, L. Sparros, B. MacMahon,
"Lung cancer and pass i ve smok i ng", I nt . J. Cancer 27: 1(1981).
3. L. Garfinkel, 0. Auerbach, L. Joubert, "Involuntary smoking
and lung cancer: a case control study", J. Nat. Cander Inst.
75:463 (1985).
4. J. L. Repace, A. H. Lowrey, "A quantitative estimate of
nonsmokers' lung cancer risk from passive smoking",
E n v i ron . I n t. JL: 3(1985).
5. Biblioaraahv on smokin9 and health, Public Health Service
Bibliography Series No. 45, Public Health Service,
Rockville, M0, 1979, 1980, 1981, 1982, 1983, 1984.
6. Smokina and health bulletin, Public Health Service,
Rockville, MD, 1985 Issues.
7. K. T. Halvorsen, Estimating aoaulation aarameters usin9
tnformation from several indeaendent sources, Doctoral
dissertation. Harvard School of Public Health, Boston, MA,
1984, P. 46.
8. Cancer Facts and Fi9ures, 1984, American Cancer Society, New
York, 1984, P. 7.
9. T. Hirayama, "Passive smoking and lung cancer", presented at
the Fifth World Conference on Smoking and Health, Winnepeg,
Canada, July, 1983.
10. 0: Trichopoulos, A. Kalandidi, L. Sparros, "Lung cancer and
passive smoking: conclusion of Greek study", Lancet ?.:677
(1983).
I1. L. Garfinkel, "Time trends in lung cancer mortality among
nonsmokers and a note on passive smoking", J. Nat. Cancer
jnst. f6:1061 (1981).
12. P. Correa, L. W. Pickle, E. Fontham, Y. Lin, W. Haenszel,
"Passive smoking and lung cao+cer", Lancet Z,:595 (1983).
13. C. R. Gillis, 0. J. Hole, V. 1!. Hawthorne, P. Boyle, "The
effect of environmental tobacco smoke In two urban
communities in the west of Scotland", Eur. J. Resa. Dis. §5
(supplement No. 133):121 (1984).
14. L. C. Koo, J. H-C. Ho, 0. Saw, "is passive smoking an added
risk factor for lupg cancer in Chinese women?"
J. Exa. Clin. Cancer Res. ).:277 (1984).
15. 0. P. Sandier, R. B. Everson, A. J. Wilcox, "Passive smoking
in adulthood and cancer risk", Am. J. Eaidemioi. _=:37
(1985).
16. A. Knoth, H. Bohn, F. Schmidt, "Passivrauchen als
Lungenkrebs-Ursache bei Nfchtraucherinnen", Medizinische
l~.tnik 78:66 (1983).
14

86-80.6
17. M~ C. Chan, M. J. Colbourne, S. C. Fung, H.. C. Ho,
"8ronchial cancer in Hong Kong 1976-1977", Br. J. Cancer
21:182 (1979). See also W. C. Chan, S. C. Fung, "Lung
cancer in non-smokers in Hong Kong", in Cancer camaaign.
Vol. 6. Cancer Eaidemioloox, E. Grundmann, ed., Gustav
Fischer Verlag, Stuttgart, New York, 1982, pp. 199-202,
which appears to be based on the same data.
18. G. C. Kabat, E. L. Wynder, "Lung cancer in nonsmokers",
Cancer Us1214 (1984).
19. A. H. Wu, 8. E. Henderson, N. C. Pike, M. C. Yu. "I§moking
and other risk factors for lung cancer in women",
J. Nat. Cancer Inst. T4:747 (1985).
20. T. Hirayama, "Cancer mortality in nonsmoking women with
smoking husbands based on a large-scale cohort study in
Japan". Preventive Med. 11:680 (1984).
21. G. H. Miller, "Cancer, passive smoking and non-employed and
employed wives", Mest. J. Med. 14Q_:632 (1984).
22. C. Garland, E. 8arrett-Connor, L. Suarez, M. H. Criqui, 0.
L. Mingard, "Effects of passive smoking on ischemic heart
disease mortality of nonsmokers", Am. J. Eoidemiol. j2,y:645
(1985).
23. K. H. Svendsen, L. H. Kuller, J. 0. Neaton, "Effects of
passive smoking in the multiple risk factor Intervention
trial (MRFIT)", presented at American Heart Association
Meeting, washington. D.C., November, 1985.
24. J. 0. Buckley, R. M. C. Harris. R. Doll, M. P. Vessey, P. T.
Miiliams, "Case-control study of the husbands of women with
dyspiasia or carcinoma of the cervix uteri". Lancet _t:10C0
(1981).
25. 0. C. Brown, L. Pereira, J. B. Garner, "Cancer of the cervix
and the smoking husband", Can. Fam. Phvsician Zj:499 (1982).
26. G. H. Miller, "The Pennsylvania study on passive smoking",
J. Breathina. Illinois Luna Assoc. _41(5):5 (1978).
27. J. P. Vandenbroucke, J. H. H. Verheesen, A. De Bruin. B. J.
Mauritz, C. Van Oer Heide-wessel, R. M. Van Der Heide,
"Active and passive smoking in married couples: results of
_25 year foilowup", 8r. Med. J. 288:1801 (1984).
28. The health consequences of smokina, cancer, a report of the
surgeon oeneral. 1982, Pubiic Health Service, Rockville, MD,
1982, pp. 145-6.
29. L. H. Garland, R. L. Beier, W. Coulson, J. H. Heald, R. L.
Stein, "The apparent sites of origin of carcinomas of the
lung", Radioloav 78:1 (1962).
30. R. G. Vincent, J. W. Pickren, M. M. Lane, 1. Bross, H.
Takita, L. Houten, A. C. Gutierrez, T. Rzepka, "The changing
histopathology of lung cancer, a review of 1682 cases",
n r 34:1647 (1977).
31. R. J. Mitchell, "Controlled measurement of smoke-particle
retention in the respiratory tract", Am. Rev. Resair. Dis..
§1:526 (1962).
32. J. L. Repace, A. H. Lowrey, "Indoor air pollution, tobacco
smoke, and public health", Science LM:464 (1980).
IS

86-80.6
33. J. Heyder, "Studies of particie deposition and clearance In
humans", in Problems of inhalatorv toxicity studies, P.
Grosdanoff, et ai., eds., MMV-Medizin-Veriag, Munich, 1985,
pp. 155-180.
34. K. McCusker, C. Hiller, M. Mazumder, R. 8one, "Dynamic
growth of cigarette smoke particles ", (Abstract), Chest
$Qs 349 (1981).
35. C. Melandri, G. Tarroni, V. Prodi, T. De Zaiacomo, H.
Formignani, C. C. Lombardi, "Deposition of charged particles
in the human airways", J. Aerosol. Sci. jAs6S7 (1989).
36. N. A. Fuchs, The mechanics of aerosols, Macmillan, New York,
1964, pp. 46-49.
37. T. R. Gerrity, P. S. Lee, F. J. Hass. A. Marinel 1 i, P.
Merner, R. V. Lourenco, "Calculated deposition of inhaled
particles in the airway generations of normal subjects", J.,,.
A_ppl,__ Ph"i_oi a Rescirat. Enviraw.-Ex__e.ccise Phvsiol.
47( 4 ) :867 (1979).
38. F. C. Hiiler, K. T. McCusker, M. K. Mazumder, J. 0. Milson,
R. C. Bone, "Deposition of sidestream cigarette smoke in
the human respiratory tract", Am. Rev. Resp. Dis. =(4):406
(1982).
39. The health consevuences of smokin9, cancer, a report of the
suraeon aenerai, 1982, Public Health Service, Rockviile, M0,
pp. 196-214.
40. G. 0. Friedman, 0. B. Petitti, R. 0. Bawol, "Prevalence and
correlates of passive smoking", Am. J. Public Health 73s401
(1983).
41. E. C. Hammond, "Smoking in relation to the death rates of
one million men and women", in gJ2_1demtolocicai approaches to
the study of cancer and other chronic diseases, M. Haenszel,
ed., Public Health Service, Bethesda, MD, 1966, pp. 127-204.
(National Cancer Institute Monograph 19).
16
